|
PDS5B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69506999999625E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.024000E-04 |
| Normal-vs-Stage2 |
4.337500E-03 |
| Normal-vs-Stage3 |
3.24669999995919E-07 |
| Normal-vs-Stage4 |
1.66702999999657E-05 |
| Stage1-vs-Stage2 |
7.705200E-01 |
| Stage1-vs-Stage3 |
3.284100E-02 |
| Stage1-vs-Stage4 |
8.450400E-02 |
| Stage2-vs-Stage3 |
2.363800E-01 |
| Stage2-vs-Stage4 |
2.717800E-01 |
| Stage3-vs-Stage4 |
8.944800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.75540000000052E-06 |
| Normal-vs-AfricanAmerican |
1.925240E-01 |
| Normal-vs-Asian |
2.739500E-03 |
| Caucasian-vs-AfricanAmerican |
1.022350E-01 |
| Caucasian-vs-Asian |
7.987200E-01 |
| AfricanAmerican-vs-Asian |
2.495600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.18230000000164E-05 |
| Normal-vs-Female |
2.4238999999926E-05 |
| Male-vs-Female |
7.588000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.362640E-03 |
| Normal-vs-Age(41-60Yrs) |
1.85238000000032E-05 |
| Normal-vs-Age(61-80Yrs) |
1.55816999999336E-05 |
| Normal-vs-Age(81-100Yrs) |
1.318170E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.671990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.394400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.223800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.990000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.603600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.445800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.062300E-02 |
| Classical-VS-Follicular |
1.100140E-02 |
| Classical-VS-Other |
2.888600E-01 |
| Classical-VS-Normal |
8.042200E-04 |
| Tall-VS-Follicular |
5.725400E-01 |
| Tall-VS-Other |
8.887200E-01 |
| Tall-VS-Normal |
2.12429999999486E-05 |
| Follicular-VS-Other |
8.536400E-01 |
| Follicular-VS-Normal |
1.63099999999083E-05 |
| Other-VS-Normal |
2.093800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.76277999999197E-05 |
| Normal-vs-N1 |
2.79560000004953E-06 |
| N0-vs-N1 |
2.552600E-01 |
|
|
